baber/WOPTO huggingface dataset:
Patent AU-2015413652-A1 (AU)
Title: Method for data transmission of LAA-LTE system, terminal, and base station
Inventor: ZHENG JUAN
IPC: H04L27/26
Filed: 2015-11-20
Abstract: The present invention relates to a method for data transmission of an LAA-LTE system, a user equipment, and an access network device. The data receiving method comprises: a user equipment determines first information of a first cell; the user equipment determines a first subframe according to the first information, wherein the downlink data transmission length of the first subframe is smaller than a first threshold; and the user equipment determines the data transmission characteristic of the first subframe in the first cell according to a preset condition, so as to receive data comprising the first subframe according to the data transmission characteristic. Therefore, by standardizing the data transmission characteristic of a base station or a terminal, the present invention ensures accurate identification of reference signals, such as DRS, and can be applied to an LTE system.
Patent WO-2016187645-A1 (WO)
Title: An lng production plant and corresponding method of construction
Inventor: FAKA SOLOMON ALADJA
IPC: B63B27/30
Filed: 2016-04-11
Abstract: An LNG production plant and a method of constructing the LNG production plant (10) is disclosed. The LNG production plant (10) comprises at least one plant module (M) and a support structure S to support the at least one plant module (M). Each plant module (M) is dry transported by a heavy lift vessel (V) and subsequently transferred to the support structure (S) without lifting the plant module (M) from a deck (84) of the vessel. The support structure (S) includes a landing substructure (41) onto which the plant module (M) is transferred from the vessel (V). Landing substructure (41) may be onshore or offshore. The support structure S may also include one or more onshore support substructures (43) and a transfer path (47) enabling a plant module (M) to be moved from the landing substructure (41) to a corresponding onshore support substructure (43).
Patent WO-2017031519-A1 (WO)
Title: Rotational driver
Inventor: SIMMONDS BRIAN
IPC: B25B13/00
Filed: 2016-08-08
Abstract: A device (1), for rotationally driving an element (15), including a rotationally-driven member (39) at a front of the device and engageable with, to transmit rotational drive to, the element. A formation (43) is shaped to contact, to transmit a reaction torque to, an attachment (33). A rearward-facing portion (59a) is at the rear, or rearward, of the formation. An arrangement engages, to act between, the rearward-facing portion and the attachment to rearwardly urge the attachment.
Patent AU-2016201544-A1 (AU)
Title: Purification of Butyrylcholinesterase Using Membrane Adsorption
Inventor: ZAYDENBERG ALEXANDER
IPC: C12N9/18
Filed: 2016-03-09
Abstract: The present invention relates to purification of butyrylcholinesterase using anion exchange material, where the butyrylcholinesterase content is enriched at least 10 fold per total protein in the composition.
Patent AU-2016202156-A1 (AU)
Title: Controlled release peptide formulations
Inventor: TIBERG FREDRIK
IPC: A61K47/24
Filed: 2016-04-06
Abstract: The present invention relates to compositions forming a low viscosity mixture of: a) 20-80 wt.% of at least one diacyl glycerol and/or a tocopherol; b) 20-80 wt.% of at least one phosphatidyl choline (PC); c) 5-20 wt.% of at least one biocompatible, organic mono alcoholic solvent; d) up to 20 wt.% polar solvent e) at least one peptide active agent; f) optionally at least one antioxidant; wherein the ratio of components a:b is in the range 40:60 to 54:46; wherein the pre-formulation forms, or is capable of forming, at least one liquid crystalline phase structure upon contact with excess aqueous fluid. The invention further relates to methods of treatment comprising administration of such compositions, and to pre filled administration devices and kits containing the formulations.
Patent AU-2016209053-A1 (AU)
Title: Interventional device having an integrated embolic filter and associated methods
Inventor: SACHAR RAVISH
IPC: A61F2/01
Filed: 2016-01-25
Abstract: A percutaneous transluminal device, comprising an elongated catheter, an interventional device operably coupled to the proximal end of the catheter, a filter operably coupled to the distal end of the catheter, the filter movable between a collapsed and deployed position 218, and an actuator wire for deploying the collapsing the filter. The filter including a filter chassis comprising a movable collar a fixed collar and a tubular braided scaffolding coupled between the movable collar and the fixed collar. Each wire of the braided scaffolding moving independently with respect to the other wires between the movable collar and the fixed collar as the filter moves between the collapsed position and the deployed position.
Patent AU-2016211132-A1 (AU)
Title: Method and product for preventing false positives in methods employing ddNTPs
Inventor: RUDI KNUT
IPC: C12Q1/68
Filed: 2016-02-01
Abstract: The present invention relates to a method which prevents undesirable binding of ddNTPs to double stranded polynucleotides when in the presence of a polymerase. Such methods may be used to prevent the appearance of false positives in methods employing ddNTPs, e.g. in sequence detection methods. The present invention also provides a method of avoiding a false Tm reading or false FRET effects (such as false positive quenching), for example in a melting curve analysis method. In particular a method is provided in which a target nucleotide sequence in a test polynucleotide is detected using a method in which a double stranded molecule is generated which may or may not comprise two labels depending on whether the target sequence is present in which the presence of the two labels is determined, preferably by performing a melting curve analysis.
Patent AU-2016222140-A1 (AU)
Title: Fused-ring compounds, pharmaceutical composition and uses thereof
Inventor: LI QUN
IPC: A61P31/12
Filed: 2016-02-03
Abstract: This disclosure is related to a fused-ring compound of formula (I) and/or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the fused ring compound of formula (I) and/or a pharmaceutically acceptable salt thereof, preparation methods thereof, and use thereof in modulating activity of indoleamine 2, 3-dioxygenase (IDO) and/or tryptophan 2, 3-dioxygenase (TDO). This disclosure further provides methods of treating IDO and/or TDO-associated diseases, including cancer, viral infection and autoimmune diseases.
Patent AU-2016225786-A1 (AU)
Title: Cooling system with low temperature load
Inventor: ZIMMERMANN AUGUSTO J PEREIRA
IPC: F25B49/02
Filed: 2016-09-05
Abstract: A system includes a temperature sensor, a pressure sensor, and a controller. The temperature sensor measures a temperature of a refrigerant at a compressor. The compressor receives the refrigerant from a second compressor. The pressure sensor 5 measures a pressure of the refrigerant at the compressor. The controller receives one or more of the measured temperature and the measured pressure and determines that one or more of the measured temperature and the measured pressure exceed a threshold. In response to that determination, the controller actuates a pulse valve coupled to a liquid injection line. The pulse valve controls the flow of a liquid 10 refrigerant from a flash tank through the liquid injection line to mix with the refrigerant at the compressor.
Patent AU-2016244223-A1 (AU)
Title: Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
Inventor: WHALLEY BENJAMIN
IPC: A61K36/185
Filed: 2016-10-11
Abstract: USE OF THE PHYTOCANNABINOID CANNABIDIVARIN (CBDV) IN THE TREATMENT OF EPILEPSY This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. The invention further relates to the use of the phytocannabinoid CBDV in combination with standard anti-epileptic drugs (SAEDs). Preferably the SAED is one of ethosuximide, valproate or phenobarbital.
Patent AU-2016247178-A1 (AU)
Title: Railway car truck with friction damping
Inventor: COSEGLIA JOHN
IPC: B61F5/12
Filed: 2016-10-21
Abstract: RAILWAY CAR TRUCK WITH FRICTION DAMPING A device is provided for addition to a three piece railway freight truck to prevent vertical over travel of the bolster (13) and absorb inertia energy of the bolster (13) before it impacts the sideframe (2, 13) or brake equipment. Two variations of this device have a gap which prevents the device from being engaged under normal operating conditions. The device utilizes an energy absorbing elastomer material mounted between the top of the bolster end (14, 15) and the bottom of the sideframe top center compression member.
Patent AU-2016254019-A1 (AU)
Title: Durable icephobic surfaces
Inventor: TUTEJA ANISH
IPC: C08G18/10
Filed: 2016-04-27
Abstract: Durable icephobic materials form anti-ice coatings on a variety of substrates, including for aircraft, powerlines, vehicles, marine structures, communications towers, outdoor equipment, and the like. The icephobic material may comprise an elastomeric polymer with a low crosslink density (e.g., ≤ 1,300 mol/m3) and low initial ice adhesion strength (e.g., τ
Patent AU-2016262645-A1 (AU)
Title: Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
Inventor: HIRAWAT SAMIT
IPC: A61P9/00
Filed: 2016-11-21
Abstract: The present invention relates to specific doses of and dosing regimens for using a 1,2,4 oxadiazole benzoic acid compound in treating or preventing diseases associated with nonsense mutations. In particular, the invention relates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseases associated with nonsense mutations.
Patent AU-2016287838-A1 (AU)
Title: Chiral zipper system for a mattress
Inventor: SCARLESKI WILLIAM JOHN
IPC: A47C27/15
Filed: 2016-07-05
Abstract: A multiple layer mattress system is disclosed which addresses the issue of degradation of the elasticity of a foam mattress core. In one embodiment, the multiple layer mattress is formed with split layers; namely, one or more comfort layers and one or more support layers. Each layer is encased with an encasement which includes complementary chiral zippers to enable the comfort layer and the support layer to be removably secured together. The chiral zippers allow the various layers to be rotated 180° relative to each other and reconnected thereto. Layers can also be added to the mattress or replaced to suit a user's comfort level. Optionally, a separate cover may be selectively secured to the top of a comfort layer and/or the bottom of the support layer for accessories. The optional bottom accessory cover may be used to provide active or passive maneuvering of the support layer relative to a foundation. The optional top accessory layer may provide for various accessories including: a protective cover; a heating pad, a smart tech cover, for example, as illustrated at lunasleep.com; a launderable cover; a pillow top and other accessories. An aftermarket mattress encasement is also disclosed that includes a top cover and a bottom cover connectable together by way of a chiral zipper system that allows accessories to be secured on top of a conventional mattress.
Patent AU-2016320865-A1 (AU)
Title: Medical device with a structured coating
Inventor: WEBER JAN
IPC: A61B17/3207
Filed: 2016-09-08
Abstract: A medical device includes a tubular body (202) having a distal end and a proximal end, a lumen (226) extending through the tubular body from the distal end to the proximal end, a wire (220) extending through the lumen from the distal end to the proximal end, and a polymeric coating (232). The wire has an outer surface. The polymeric coating is on at least a portion of the outer surface of the wire. The coating comprises a bulk material and a plurality of flexible microstructures disposed on the bulk material. The microstructures extend outwardly from a surface of the polymeric coating.
Patent AU-2016336061-A1 (AU)
Title: Wound dressing with elastic properties for contouring to the shape of a limb
Inventor: BARBERIO ALESSANDRO
IPC: A61F13/56
Filed: 2016-10-05
Abstract: In accordance with an aspect of the present invention, there is provided a wound dressing with elastic properties for use with a human or an animal. The wound dressing includes a plurality of individual segments, each segment connected to at least one other segment by an elastic connector, and each segment having at least two perforated layers, with at least one layer having a plurality of protrusions. The wound dressing further includes a plurality of spacing elements, with each spacing element disposed between adjacent segments and retained by either the adjacent segments or the elastic connector.
Patent AU-2016350690-A1 (AU)
Title: Methods for the preparation of obeticholic acid and derivatives thereof
Inventor: GALVIN GABRIAL M
IPC: A61K31/575
Filed: 2016-10-28
Abstract: The present application relates to a method of preparing a bile acid derivative, or a pharmaceutical acceptable salt, solvate, or amino acid conjugate thereof, comprising direct alkylation at the C-6 position of KLCA.
Patent AU-2016356474-A1 (AU)
Title: Method for calibrating a data set of a target analyte
Inventor: CHUN JONG YOON
IPC: G16B45/00
Filed: 2016-11-21
Abstract: The present invention relates to a method for calibrating a data set of a target analyte in a sample, wherein a normalization coefficient for calibrating the data set is provided by using a reference value, a reference cycle and the data set, and the calibrated data set is obtained by applying the normalization coefficient to the signal values of the data set. The present method is very effective in removing the inter- and intra-instrument signal variations of data sets. Furthermore, since the present method can be configured in software, the instant method is capable of being applied universally to various analytical instruments (e.g., a real-time PCR instrument) regardless of manufacturer. Accordingly, the method by the present invention would be very useful in diagnostic data analysis.
Patent AU-2016378477-A1 (AU)
Title: Improved process for making crotonylaminopyridines
Inventor: BERGER MICHAEL
IPC: C07D213/74
Filed: 2016-12-22
Abstract: An improved process for producing a compound of Formula (I).
Patent WO-2018053578-A1 (WO)
Title: Compositions isotopiques
Inventor: KAMBOURIS AMBROSIOS
IPC: B01D3/14
Filed: 2017-09-15
Abstract: La présente invention concerne une boisson et une composition dermatologique comprenant des molécules d'eau, les molécules d'eau ayant des atomes d'oxygène de différents isotopes, la boisson étant enrichie dans au moins l'un des isotopes d'oxygène, l'enrichissement étant en référence à (i) la quantité de cet isotope d'oxygène dans l'eau utilisée pour produire la boisson ou (ii) la quantité de cet isotope d'oxygène dans l'eau souterraine, ou (iii) l'eau océanique moyenne normalisée de Vienne. Les molécules d'eau peuvent être dérivées d'une source végétale, telle qu'un jus, une sève ou une eau d'arbre.
Patent AU-2017200968-A1 (AU)
Title: Light Source Module
Inventor: LIU YUN-ZHAO
IPC: F21L4/04
Filed: 2017-02-13
Abstract: A light source module comprises a substrate at an inner side of a fixing plate, a heat dissipation plate at an inner side of the substrate, a 5 fixing base for elastic element at an inner side of the heat dissipation plate, a positive and a negative electrode elastic element. The substrate is connected with an illuminate element and formed with a positive and a negative electrode connecting portion for respectively connecting to the positive and negative electrodes of the illuminate element. The positive io and negative electrode elastic elements are sleeved the fixing base and respectively formed with a positive and a negative electrode pin to connect to the positive and negative electrode connecting portions. Accordingly, the assembly is easier and more convenient, the bad connection or short circuit is not occurred, and the inner resistance and is the power consumption are decreased. Qq
Patent AU-2017204337-A1 (AU)
Title: Stable and soluble antibodies inhibiting vegf
Inventor: BORRAS LEONARDO
IPC: C07K16/22
Filed: 2017-06-27
Abstract: The present invention relates to soluble and stable anti-VEGF immunobinders comprising CDRs from rabbit monoclonal antibodies. Said antibodies are designed for the diagnosis and/or treatment of VEGF-mediated disorders. The hybridomas, nucleic acids, vectors and host cells for expression of the recombinant antibodies of the invention, methods for isolating them and the use of said antibodies in medicine are also disclosed.
Patent AU-2017210505-A1 (AU)
Title: Improved Guard Rail Assembly
Inventor: WALLACE HAYDEN
IPC: E04H12/00
Filed: 2017-08-01
Abstract: Abstract A post and guard rail assembly, said post including an elongated mounting hole for connecting said guard rail directly to said post by means of a bolt passing through said guard rail and said mounting hole, said mounting hole being located below an upper edge of said post, said post including an aperture or slot spaced from said mounting hole and below said upper edge, whereby in the event of a collision by a vehicle with said assembly, a portion of a periphery of said aperture or slot will separate to allow said bolt and said guard rail to move from said post.
Patent AU-2017217357-A1 (AU)
Title: System for preparation of beverages with the use of capsules
Inventor: BOLOGNESE DANILO
IPC: A47J31/06
Filed: 2017-02-10
Abstract: The infusion assembly (1) comprises a capsule-holder (2) and a cooperating body (3), adapted to assume an open configuration for positioning a capsule (C) therebetween, and a closed configuration for preparing a beverage through the capsule (C) clamped in a liquid- tight manner therebetween. In the capsule-holder (2) there is defined a recess (4) adapted to receive a capsule (C) with the bottom wall (20a, 20f) facing the interior of the capsule- holder (2) and wherein is provided a first piercing member (8) provided with at least a piercing point (9) adapted to penetrate through the bottom wall (20a) of said capsule (C). The capsule-holder (2) is adapted to supply a flow of fluid introduced into the capsule (C) through the tear created in its bottom wall (20a) from the at least one point (9). In the cooperating body (3) a dispensing conduit (13) is defined for the beverage and a second piercing member (14) is provided, having at least one point (16) adapted to pene¬ trate through the cover (21) of the capsule (C) to allow the outflow of the beverage from the capsule (C) towards said dispensing conduit (13). In the capsule-holder (2) there are provided fluid communication passages (8c; 8d; 11), which put into communication a region upstream of the first piercing member (8) such that, during the preparation of a beverage, the fluid introduced into the recess (4) of the capsule-holder (2) exerts on the first piercing member (8) a force lower than a predeter¬ mined value towards the capsule (C), the first piercing member (8) being mounted in the recess (4) of the capsule-holder (2) such as to be movable under the action of a spring (10) tending to displace it towards the cooperating body (3).
Patent AU-2017218143-A1 (AU)
Title: Adipose tissue derived mesenchymal stromal cell conditioned media and methods of making and using the same
Inventor: GANGARAJU RAJA SHEKHAR
IPC: A61K35/28
Filed: 2017-02-13
Abstract: Provided herein are lyophilized compositions containing the secretome of cultured adipose cells, pharmaceutical compositions that additionally contain a sustained release drug delivery matrix, as well as methods of making and using such compositions.
Patent AU-2017228635-A1 (AU)
Title: A panel mount system
Inventor: ALLEN WARWICK
IPC: F16S1/02
Filed: 2017-09-14
Abstract: - 29 A panel mount for non penetrative fastening of a panel (such as a glass pane) able to be mounted to a structure, and preferably to a vertical or side surface of that structure, which provides a pair of clamp jaws defining an elongate slot in which an 5 edge of a panel can be received and an intermediate clamping member associated with each jaw, each intermediate clamping member having at least one threaded member associated therewith to facilitate adjustment of the position and orientation of the intermediate member within the clamp jaw so as to securely retain the panel within the slot.
Patent AU-2017232497-A1 (AU)
Title: Frozen beverage composition containing hydrolyzed pea protein
Inventor: RYAN SANDRA C
IPC: A23L2/54
Filed: 2017-03-15
Abstract: A frozen beverage composition containing hydrolyzed pea protein, and methods of making the same. The addition of hydrolyzed pea protein to non-carbonated frozen beverages has been found to produce aeration, density, and mouth feel similar to that of a carbonated frozen beverage.
Patent AU-2017239619-A1 (AU)
Title: Information terminal device, motion capture system, and motion capture method
Inventor: KAJI KUNIHIKO
IPC: G06F1/16
Filed: 2017-10-06
Abstract: The present invention combines devices having different functions according to an application, and improves convenience for a user. There is provided a wearing type terminal 1 having an external case 10 having a display unit 131 on the upper surface side and belt members 4a and 4b which can be connected to the both sides of the external case 10 respectively; and a docking type device 2 which is detachably engaged with the bottom portion of the external case 10 of the wearing type terminal 1, and is electrically connected to the wearing type terminal 1 via a dock side connection terminal 21. The wearing type terminal 1 and the docking type device 2 are provided with a function which carries out transmission and receiving of data to be displayed on the display unit 131 via the dock side connection terminal 21. P260350D1_13713844_1
Patent AU-2017248441-A1 (AU)
Title: CD37-Binding Molecules and Immunoconjugates Thereof
Inventor: DECKERT JUTTA
IPC: A61K39/395
Filed: 2017-10-17
Abstract: Novel anti-cancer agents, including, but not limited to, antibodies and immunoconjugates, that bind to CD37 are provided. Methods of using the agents, antibodies, or immunoconjugates, such as methods of inhibiting tumor growth are further provided.
Patent AU-2017250815-A1 (AU)
Title: Humanized anti-PACAP antibodies and uses thereof
Inventor: LOOMIS MARIA-CRISTINA
IPC: C07K19/00
Filed: 2017-04-14
Abstract: The present invention is directed to antibodies and antigen binding fragments thereof having binding specificity for PACAP. The antibodies and antigen binding fragments thereof comprise the sequences of the VH, VL, and CDR polypeptides described herein, and the polynucleotides encoding them. Antibodies and antigen binding fragments described herein bind to and/or compete for binding to the same linear or conformational epitope(s) on human PACAP as an anti-PACAP antibody. The invention contemplates conjugates of anti-PACAP antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. Methods of making said anti-PACAP antibodies and antigen binding fragments thereof are also contemplated. Other embodiments of the invention contemplate using anti-PACAP antibodies, and binding fragments thereof, for the diagnosis, assessment, and treatment of diseases and disorders associated with PACAP and conditions where antagonism of PACAP-related activities, such as vasodilation, photophobia, mast cell degranulation, and/or neuronal activation, would be therapeutically beneficial.